After grouping by high and low STAT1, the high-STAT1 patient visits showed a significantly increased slope for CCL2/IFN and CXCL10/IFN scores compared to low-STAT1 SLE patient visits. This evidence concerns the gene CXCL10 and systemic lupus erythematosus.